AI-discovered ALS drug trial uses unique remote monitoring
Drug Discovery World
JANUARY 11, 2024
Verge Genomics has initiated a Phase Ib proof-of-concept study for the treatment of sporadic and familial forms of amyotrophic lateral sclerosis (ALS) with VRG50635. ALS is a progressive neurodegenerative disease that affects motor neuron cells in the brain and spinal cord causing progressive paralysis of voluntary muscles.
Let's personalize your content